Emerge Australia have said that they are happy for their letter to QMUL to be circulated earlier than their e-newsletter to demonstrate their support. They say the more visability the better. Here is the text of their letter:
Emerge Australia letter to QMUL:
Professor Simon Gaskell
President and Principal Queen Mary’s University London
Mile End Road London E1 4NS
United Kingdom
20th March 2016
Call for release of PACE trial data and independent analysis of data
Dear Professor Gaskell,
Emerge Australia is a not-for-profit organisation that supports people with ME/CFS and associated conditions. We are writing as an organisation representing and supporting Australians with ME/CFS, to express our concern about Queen Mary University of London’s (QMUL) refusal to comply with the UK Information Commissioner's order to release the PACE trial anonymised raw data.
As QMUL is seeking the “advice of patients" on the matter, we are writing to convey our view to you. We support the request of an 11,000-signature petition hosted by the ME patient-advocacy organisation, ME Action Network, which asked “the study authors… to give independent researchers full access to the raw data”.1
Currently, much of the information available to Australian medical practitioners is based on the PACE trial, (in particular, the Royal Australian College of General Practitioners' website). However, eminent scientists have identified serious flaws in the PACE trial data analyses, putting the authors’ claims of patient recovery in serious doubt .2
Contrary to the PACE trial authors' claims, GET can be extremely harmful to people with ME/CFS. In 2015, Federation University Australia undertook an extensive research study into the health and wellbeing of Australian’s with ME/CFS. Preliminary findings of the survey (unpub.) show that 90% of the 608 respondents said that increasing their level of exercise/activity makes them feel worse. In the UK's ME Association's 2012 patient survey, 74% of the 233 people who tried GET report that their condition worsened.3 This anecdotal evidence is supported by studies reporting abnormal physiological responses to exercise in people with ME/CFS.4
PACE-style GET and CBT are based on the underlying rationale that ME/CFS is the result of activity avoidance and deconditioning. This view is at odds with the Institute of Medicine's (IOM) determination that "ME/CFS is a serious, chronic, complex and multisystem disease that frequently and dramatically limits the activities of affected patients".5 It is also at odds with the findings of eminent Australian researchers on the bio-medical basis of ME/CFS (Staines, Marshall- Gradnisik).6
Given these concerns with the trial, and in the interest of open and transparent science, we request that QMUL to comply with the Information Commissioner’s request to release the PACE trial data to independent researchers for reanalysis.
Yours sincerely,
Sally Missing President
cc: Rachael Cragg Group Manager Information Commissioner's Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF United Kingdom
ENDS